A randomised, double blind, parallel, placebo controlled, drug-drug interaction study to investigate the safety, tolerability and pharmacokinetics of multiple doses of HTL0018318 given alone and in combination with donepezil at steady state in elderly volunteers.
Phase of Trial: Phase I
Latest Information Update: 10 Aug 2017
At a glance
- Drugs HTL 18318 (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Heptares Therapeutics
- 05 Aug 2017 Status changed from not yet recruiting to completed.
- 23 Feb 2017 New trial record